INTRODUCTION AND OBJECTIVES: New protein toxin therapies directly injected into the prostate are in clinical trials for prostatic diseases. A major challenge is predictable control of distribution.
Magnetic resonance imaging (MRI) can potentially provide useful insight into the movement of liquid agents within organs after injection. Our objectives are to evaluate the distribution of injected liquids as a function of prostate anatomy and physiology, and of device design METHODS: Injections of MRI contrast reagents were placed into 18 ex-vivo human prostates after surgical excision in standard of care therapy for invasive bladder cancer patients, with IRB approval. Contrast agents were infused into the specimens via standard hollow needles and needles with a porous customizable length, and their performances were compared. MRI images were acquired using sequences to quantify volume delivered, distribution, and backflow.
RESULTS: MRI analysis revealed heterogeneous distribution of infusates in the specimens. Tracer distribution in the tissue was significantly higher in the porous needle [1480 AE 802 ul vs 624 AE 767 ul, p-value ¼ 0.036]. The porous needle design demonstrated a 3-fold greater delivery of infusate into the ex vivo prostate, a 2-fold greater volume of distribution, and 2-fold greater fraction of infused distribution compared to standard needle. The volume of distribution divided by the amount infused (Vd/Vi) increased by 80% with the porous needle, though no statistically significant association due to small sample size.
CONCLUSIONS: This study demonstrated that prostatic tissue is anatomically heterogeneic, which presents considerable challenge to achieving a desired distribution, particularly from a standard needle. Use of a porous needle provides improved distribution over the standard needle. MRI demonstrated infusate distribution and obstacles, and may be of value in pre-injection therapy planning. METHODS: We tested the Caiman 5(C5), Harmonic Scalpel Ace Plus (HA), Harmonic Ace þ7 (HA7), LigaSure (LS) and Enseal G2 (ES) on small (2-5mm), medium (5.1-7mm) and large (7.1-9mm) vessels in 16 Yorkshire pigs. Vessels were randomized to one of the five devices and e710 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 then were sealed and transected. Sealing and transection time, thermal spread and burst pressures (BP) were recorded for each trial. The surgeon subjectively rated charring/carbonization, tissue sticking, seal quality and transection quality on a 1-5 scale (1 best and 5 worst). Specimens were sent for histopathologic evaluation of seal quality and thermal spread. BP was measured by inserting an 18-gauge angiocatheter into the lumen of each vessel and pressurizing the irrigant until the vessel ruptured or the seal failed. The angiocatheter was then attached to a digital pressure manometer. BP failure was defined as rupture at pressures less than 300mHg for arteries and 30mmHg for veins. RESULTS: A total of 246 vessels were evaluated; 125 were arteries and 121 were veins.
Arteries: There was no difference in BP for small size arteries. However the ES had a 10% BP failure rate. For medium arteries the C5 provided the highest BP (proximal and distal jaw), followed by HA7, ES, LS and HA. All mean pressures were more than two times super physiologic for all devices. However, for HA there was a 20% failure rate and for ES the failure rate was 40% at mean pressures of 320 and 480 respectively. For large arteries C5 and LS provided highest BP followed by HA7, ES and HA: 1,676, 530, 467, 467 and 254 mmHg, respectively. HA had BP failure of 40% while ES had a failure rate of 80%, respectively. Veins: The C5 provided the highest BP (proximal and distal jaw) across all vein sizes followed by LS, HA7 and HA. Among the small, medium and large veins (up to 9mm), there were no BP failures for all the devices. With regard to thermal spread, all of the devices had similar outcomes with an average of 1 to 2 mm on either side of the jaws.
CONCLUSIONS: In this study, the C5 outperformed all other devices. Thermal spread is minimal with all devices. With all devices, the seal remained intact up to pressures of 250 mm Hg or twice physiologic; of note, the seals with the C5, HA7, and LS were stronger than the vessel wall itself.
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MP52-18 EVALUATION OF A NOVEL THREE-DIMENSIONAL FUNNEL MESH FOR PARASTOMAL HERNIA REPAIR AFTER ILEAL CONDUIT DIVERSION
Karl Tully*, Bochum, Germany; Florian Roghmann, Jobst Pastor, Rein J€ uri Palisaar, Joachim Noldus, Christian von Bodman, Herne, Germany INTRODUCTION AND OBJECTIVES: Using cross-sectional imaging parastomal hernia (PSH) is detected with a frequency of up to 65% in patients treated with cystectomy and ileal conduit (IC) diversion. While many patients initially remain asymptomatic, up to 30% need surgical repair due to clinical symptoms impacting quality of life. Common repair methods to treat this most frequent complication after IC diversion using native tissue show unacceptable high recurrence rates (>70%), which has led to mesh based repair techniques. Effective and safe surgical techniques and outcomes need to be reported in the urologic literature. We report our open surgical technique and results using an intraperitoneal onlay mesh with a central funnel for the conduit aiming to minimize mesh penetration and PSH recurrence. METHODS: Between 1/2004 and 12/2015, 643 patients were treated with ileal conduit urinary diversion at our institution. Subsequently 40 Patients (6,2%) underwent open PSH repair between 2/2009 and 3/ 2016 using a novel intraperitoneal-onlay-mesh with a central hole (2cm diameter) and funnel for intestinal parts (DynaMesh IPST). As surgical access we used a 4 cm longitudinal incision below and above the stoma. The mesh was placed intraperitoneally as an onlay and fixed at four corner points with non-absorbent sutures. Patients received clinical and ultrasound follow-up to monitor treatment success and effectiveness. While perioperative data was available for 40 patients, 13 could not be followed at our institution, leading to 27 patients with follow-up data.
RESULTS: Of the 40 patients perioperatively only one patient developed a wound infection, which was managed with multiple surgical debridements keeping the mesh in place.27 Patients (16 male, 11 female) with a median age of 74 years and a median BMI of 29.4 kg/m 2 (IQR 25; 31) could be followed with a median follow up of 29 months (IQR 16; 63) . Two patients developed a stoma stenosis (7%) with consecutive dilation of the renal pelvis which needed to be drained with a nephrostomy. Only two patients (7%) developed a PSH recurrence after mesh implant with one of them being in need of revision at last follow-up. No patient showed a penetration of the mesh into the intestine, stoma necrosis or stoma prolapse.
CONCLUSIONS:
The described open surgical technique shows a low perioperative complication rate and a promising low PSH recurrence rate of only 7%. A specifically designed 2-component mesh with a central funnel implanted as an intraperitoneal onlay seems to provide an effective treatment option for PSH repair after ileal conduit diversion. (Fig. 1a ). We used a transparent attachment with a tube of diameter 2.8-mm (Impact Shooter N type 6.0-mm diameter; Top Co.). It is designed for devices such as ESD knives and enables the endoscope to work like a dual channel scope (Fig. 1b) . We used an electrosurgical knife (Dual Knife, 2.7-mm diameter; OLYMPUS), commonly used for gastrointestinal tract 0 s ESD (Fig. 1c) . A circular area of 1.0-2.0-cm diameter was defined in the bladder and identified as the target area for resection ( Fig.2a-c) .
Source of
RESULTS: The ESD technique was applied into 5 places of bladder per cadaver. Although the target areas were successfully resected from the four cadavers ( Fig.2d ), one small bladder perforation occurred. In total 20 procedures, the median size of the resected pieces ex vivo was 1.4 cm (range 0.8-2.0 cm), and the median time taken to resect each target piece was 9.0 min (range 4.0e17.0 min). Endoscopic procedures of bladder using a flexible cystoscope with an Impact shooter was technically feasible in the human male cadavers. However, the handling of the tool was slightly difficult because of the poor flexibility of the additional attachment and the influence of the relative hardness of the urethra of cadavers as compared to healthy persons.
CONCLUSIONS: Transurethral ESD technique using a flexible cystoscope was considered technically feasible for the small bladder tumors. We hope that in the near future a new flexible cystoscope with dual and large caliber channels will be developed in order to facilitate ESD technique.
